Literature DB >> 11302804

Activities of bismuth thiols against staphylococci and staphylococcal biofilms.

P Domenico1, L Baldassarri, P E Schoch, K Kaehler, M Sasatsu, B A Cunha.   

Abstract

Indwelling medical devices are associated with infectious complications. Incorporating antimicrobials into indwelling materials may reduce bacterial colonization. Bismuth thiols are antibiofilm agents with up to 1,000-fold-greater antibacterial activity than other bismuth salts. Staphylococci are particularly sensitive, as determined by agar diffusion and broth dilution susceptibility testing. Bismuth-ethanedithiol inhibited 10 methicillin-resistant Staphylococcus epidermidis strains at 0.9 to 1.8, Staphylococcus aureus ATCC 25923 at 2.4, and S. epidermidis ATCC 12228 at 0.1 microM Bi(3+). Antiseptic-resistant S. aureus was sensitive to bismuth-2-3-dimercaptopropanol (BisBAL) at < or = 7 microM Bi(3+). Hydrogel-coated polyurethane rods soaked in BisBAL inhibited S. epidermidis for 39 days (inhibitory zone diameter in agar, > or = 30 mm for > 25 days). Slime from 16 slime-producing S. epidermidis strains was inhibited significantly by bismuth-3,4-dimercaptotoluene (BisTOL), but not by AgNO3, at subinhibitory concentrations. In conclusion, bismuth-thiols are bacteriostatic and bactericidal against staphylococci, including resistant organisms, but are also inhibitors of slime at subinhibitory concentrations. At subinhibitory concentrations, BisTOL may be useful in preventing the colonization and infection of indwelling intravascular lines, since staphylococci are important pathogens in this setting.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11302804      PMCID: PMC90482          DOI: 10.1128/AAC.45.5.1417-1421.2001

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  23 in total

Review 1.  Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks.

Authors:  J Kluytmans; A van Belkum; H Verbrugh
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Characterization of the importance of polysaccharide intercellular adhesin/hemagglutinin of Staphylococcus epidermidis in the pathogenesis of biomaterial-based infection in a mouse foreign body infection model.

Authors:  M E Rupp; J S Ulphani; P D Fey; K Bartscht; D Mack
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

3.  Enhancement of bismuth antibacterial activity with lipophilic thiol chelators.

Authors:  P Domenico; R J Salo; S G Novick; P E Schoch; K Van Horn; B A Cunha
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

4.  The Structurally Flexible Bicyclic Bis(2-hydroxyethanethiolato)bismuth(III) Complex: A Model for Asymmetric Monoanionic Chelation of Bismuth(III).

Authors:  Lisa Agocs; Glen G. Briand; Neil Burford; T. Stanley Cameron; Witold Kwiatkowski; Katherine N. Robertson
Journal:  Inorg Chem       Date:  1997-06-18       Impact factor: 5.165

Review 5.  Bacterial biofilms in nature and disease.

Authors:  J W Costerton; K J Cheng; G G Geesey; T I Ladd; J C Nickel; M Dasgupta; T J Marrie
Journal:  Annu Rev Microbiol       Date:  1987       Impact factor: 15.500

6.  Variable fixation of staphylococcal slime by different histochemical fixatives.

Authors:  L Baldassarri; W A Simpson; G Donelli; G D Christensen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-11       Impact factor: 3.267

7.  Infection and intravenous catheters.

Authors:  S J Eykyn
Journal:  J Antimicrob Chemother       Date:  1984-09       Impact factor: 5.790

8.  Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial.

Authors:  D G Maki; S M Stolz; S Wheeler; L A Mermel
Journal:  Ann Intern Med       Date:  1997-08-15       Impact factor: 25.391

9.  Regulation of slime production in Staphylococcus epidermidis by iron limitation.

Authors:  M Deighton; R Borland
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

10.  The broad-spectrum activity and efficacy of catheters coated with minocycline and rifampin.

Authors:  I Raad; R Darouiche; R Hachem; M Mansouri; G P Bodey
Journal:  J Infect Dis       Date:  1996-02       Impact factor: 5.226

View more
  14 in total

1.  Contribution of phosphoglucosamine mutase to determination of bacterial cell morphology in Streptococcus gordonii.

Authors:  Kisaki Shimazu; Yukihiro Takahashi; Hiroyuki Karibe; Fusako Mitsuhashi; Kiyoshi Konishi
Journal:  Odontology       Date:  2011-05-13       Impact factor: 2.634

Review 2.  Nanomedicine and advanced technologies for burns: Preventing infection and facilitating wound healing.

Authors:  Mirza Ali Mofazzal Jahromi; Parham Sahandi Zangabad; Seyed Masoud Moosavi Basri; Keyvan Sahandi Zangabad; Ameneh Ghamarypour; Amir R Aref; Mahdi Karimi; Michael R Hamblin
Journal:  Adv Drug Deliv Rev       Date:  2017-08-04       Impact factor: 15.470

3.  Inhibition of bacterial adherence on the surface of stents and bacterial growth in bile by bismuth dimercaprol.

Authors:  Hongjun Zhang; Javon Tang; Xangwen Meng; Jackie Tsang; Tat-Kin Tsang
Journal:  Dig Dis Sci       Date:  2005-06       Impact factor: 3.199

4.  Antibacterial properties of some cyclic organobismuth(III) compounds.

Authors:  Toshiaki Kotani; Daisuke Nagai; Kensuke Asahi; Hitomi Suzuki; Fumiaki Yamao; Nobumasa Kataoka; Tatsuo Yagura
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

5.  Bismuth coating of non-tunneled haemodialysis catheters reduces bacterial colonization: a randomized controlled trial.

Authors:  Ralf Schindler; Uwe Heemann; Ulrike Haug; Benjamin Stoelck; Aysun Karatas; Cosima Pohle; Reinhold Deppisch; Werner Beck; Markus Hollenbeck
Journal:  Nephrol Dial Transplant       Date:  2010-03-17       Impact factor: 5.992

6.  The action of bismuth against Helicobacter pylori mimics but is not caused by intracellular iron deprivation.

Authors:  Michael V Bland; Salim Ismail; Jack A Heinemann; Jacqueline I Keenan
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

Review 7.  Anti-biofilm strategies and the need for innovations in wound care.

Authors:  Mary C B Ammons
Journal:  Recent Pat Antiinfect Drug Discov       Date:  2010-01

8.  Vancomycin-modified implant surface inhibits biofilm formation and supports bone-healing in an infected osteotomy model in sheep: a proof-of-concept study.

Authors:  Suzanne Stewart; Stephanie Barr; Julie Engiles; Noreen J Hickok; Irving M Shapiro; Dean W Richardson; Javad Parvizi; Thomas P Schaer
Journal:  J Bone Joint Surg Am       Date:  2012-08-01       Impact factor: 5.284

Review 9.  Helicobacter pylori Biofilm Formation and Its Potential Role in Pathogenesis.

Authors:  Skander Hathroubi; Stephanie L Servetas; Ian Windham; D Scott Merrell; Karen M Ottemann
Journal:  Microbiol Mol Biol Rev       Date:  2018-05-09       Impact factor: 11.056

10.  Antibiofilm activity of GlmU enzyme inhibitors against catheter-associated uropathogens.

Authors:  Euan Burton; Purushottam V Gawande; Nandadeva Yakandawala; Karen LoVetri; George G Zhanel; Tony Romeo; Albert D Friesen; Srinivasa Madhyastha
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.